Beta oxidation
(Redirected from Fatty acid oxidation)
Beta oxidation is a metabolic process involving multiple steps by which fatty acid molecules are broken down within the mitochondria in eukaryotic cells, and in the cytoplasm of prokaryotic cells. This process generates acetyl-CoA, which enters the citric acid cycle, and NADH and FADH2, which are co-enzymes used in the electron transport chain. It is named 'beta oxidation' because the beta carbon of the fatty acid undergoes oxidation to a carbonyl group.
Process[edit | edit source]
Beta oxidation consists of four steps: dehydrogenation, hydration, another dehydrogenation, and finally thiolytic cleavage. Each step is facilitated by a specific enzyme.
- Dehydrogenation: The first step in beta oxidation is the oxidation of the fatty acid by acyl-CoA dehydrogenase to create a trans double bond between the alpha and beta carbons. This process generates one molecule of FADH2.
- Hydration: In the second step, water is added to the fatty acid by enoyl-CoA hydratase to form a beta-hydroxy group. This step is an example of stereospecificity, as only the L isomer of the molecule is produced.
- Second Dehydrogenation: The third step is another oxidation, this time of the beta-hydroxy group to a keto group. This step is catalyzed by hydroxyacyl-CoA dehydrogenase, and generates one molecule of NADH.
- Thiolytic Cleavage: The final step is the cleavage of the beta-ketoacyl CoA by thiolase, releasing an acetyl-CoA molecule and a fatty acid chain shortened by two carbon atoms.
Regulation[edit | edit source]
Beta oxidation is regulated by a number of factors, including the availability of fatty acids, the levels of malonyl-CoA, and the energy status of the cell. The rate of beta oxidation can be increased by exercise, fasting, and low-carbohydrate diets.
Clinical Significance[edit | edit source]
Defects in beta oxidation can lead to a number of metabolic disorders, including medium-chain acyl-CoA dehydrogenase deficiency (MCADD), long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD), and carnitine deficiency. These conditions can lead to symptoms such as hypoglycemia, lethargy, and muscle weakness, and can be life-threatening if not properly managed.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD